Therapy-induced cellular senescence in cancer cells, or at least a senescence-like phenotype, has already been shown to be a crucial phenotype after chemotherapy [42,43,44,45,46], radiotherapy [44,45,47,48,49], and more recently also after Plk1 inhibition [21,50,51]. The gene discussed is PLK1; the disease is cancer.